Summary
The effect of age on the pharmacokinetics of erythromycin was investigated by comparing its kinetic behaviour in eight young healthy adults and eight healthy elderly subjects after single and repeated oral doses of erythromycin stearate 1 g b.d. for 7 doses.
The peak serum concentration and area under the serum concentration-time curve (AUC) were significantly greater in the elderly subjects than in the young controls after single and multiple doses. Accordingly, the apparent oral clearance was lower in the elderly subjects (0.31 vs 0.64 and 0.22 vs 0.69 l·h−1·kg−1 after the first and seventh administration, respectively). The mean elimination half-life was significantly longer in the elderly group only after multiple dosing (4.8 vs 2.3 h).
No age-related difference was observed in the time to peak serum concentration and apparent volume of distribution. The multiple-dose regimen resulted in an almost two-fold accumulation of erythromycin in the older individuals and no accumulation in the young adults. Mean drug accumulation in elderly subjects at steady state was 43% greater than was predicted from the AUC after the first dose, suggesting a time-dependent reduction in both systemic and presystemic clearance.
The results indicate that the metabolic elimination processes for erythromycin are impaired in normal elderly subjects and suggest that caution is required on administering a high dose of it to aged people.
Similar content being viewed by others
References
Greenblatt DJ, Sellers EM, Shader RI (1982) Drug disposition in old age. N Engl J Med 306: 1081–1088
Triggs EJ, Hooper WD, Dickinson RG (1984) The influence of age on drug metabolism. Med J Aust 141: 823–827
Shmucker DL (1985) Aging and drug disposition: an update. Pharmacol Rev 37: 133–148
Schweitzer VG, Olson NR (1984) Ototoxic effect of erythromycin therapy. Arch Otolaryngol 110: 258–260
Midtvedt T (1987) Miscellaneous antibiotics. In: Dukes MNG (ed) Side effects of Drugs Annual 11. Elsevier, Amsterdam
Ljungberg B, Nilsson-Ehle I (1987) Pharmacokinetics of antimicrobial agents in the elderly. Rev Infect Dis 9: 250–264
Periti P, Mazzei T, Mini E, Novelli A (1989) Clinical pharmacokinetic properties of the macroldide antibiotics. Effect of age and various pathophysiological states (Part I). Clin Pharmacokinet 16: 193–214
Washington JA, Wilson WR (1985) Erythromycin: a microbial and clinical perspective after 30 years of clinical use (First of two parts). Mayo Clin Proc 60: 189–203
Nilsen OG (1987) Comparative pharmacokinetics of macrolides. J Antimicrob Chemother 20 [Suppl B]: 81–88
Colburn WA, Di Santo AR, Gibaldi M (1977) Pharmacokinetics of erythromycin on repetitive dosing. J Clin Pharmacol 17: 592–600
Mather LE, Austin KL, Philpot CR, McDonald PJ (1981) Absorption and bioavailability of oral erythromycin. Br J Clin Pharmacol 12: 131–140
Gibaldi M, Perrier D (1982) Pharmacokinetics. Dekker, New York
Austin KL, Mather LE, Philpot CR, McDonald PJ (1980) Intersubject and dose-related variability after intravenous administration of erythromycin. Br J Clin Pharmacol 10: 273–279
Josefsson K, Bergan T, Magni L (1982) Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base. Br J Clin Pharmacol 13: 685–691
Danan G, Descatoire V, Pessayre D (1981) Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. J Pharmacol Exp Ther 218: 509–514
Larrey D, Funck-Brentano C, Breil P, Vitaux J, Theodore C, Babany G, Pessayre D (1983) Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. Biochem Pharmacol 32: 1063–1068
Mery JP, Kanfer A (1979) Ototoxicity of erythromycin in patients with renal insufficiency (letter). N Engl J Med 301: 944
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miglioli, P.A., Pivetta, P., Strazzabosco, M. et al. Effect of age on single- and multiple-dose pharmacokinetics of erythromycin. Eur J Clin Pharmacol 39, 161–164 (1990). https://doi.org/10.1007/BF00280051
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280051